… synergistic combinations that should be explored include pemetrexed … pemetrexed need
to be investigated, including the potential role of TS messenger RNA. In summary, pemetrexed …

… Thus, the pemetrexed–platinum backbone provides an attractive option for combination with
… of pemetrexed–platinum as a backbone for combination with targeted therapies for NSCLC. …

… pemetrexed and its activity against a wide range of solid tumors.7 Another early Phase I
study established the safety of pemetrexed in combination … from Australia, pemetrexed as first-…

… of advanced non-small cell lung cancer (NSCLC), the … cytotoxic agent, pemetrexed, and its
combination with platinums … ) to pemetrexed/platinum in NSCLC, and the role of pemetrexed/…

… The Phase III Zactima Efficacy with Alimta in Lung cancer (ZEAL) trial is currently ongoing
to study the effect of pemetrexed combined with vandetanib in patients with locally-advanced …

… Pemetrexed, a novel multi-targeted agent established for the treatment of mesothelioma, …
-cell lung cancer (NSCLC). In the present trial we investigated pemetrexed in combination with …

… Dark, GG Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in
advanced non-small cell lung cancer: a multicenter, randomized, phase II trial Clin Cancer Res 11…

… The primary objective of the current combined analysis of three large phase 3 trials was
to determine the comparability (overall and by histology) of pemetrexed–cisplatin with other …

… Inthisreport,wecomparetheefectsandtoxicities in advanced NSCLC patients treated with
pemetrexed monotherapyversuspemetrexedplusplatinum combination agentso as co provide a …

… 11, 12 suggest that pemetrexed plus carboplatin is a tolerable … and efficacy of pemetrexed
combined with either cisplatin or … pemetrexed plus cisplatin or pemetrexed plus carboplatin. …